Study: Pfizer and Moderna vaccines prevent COVID-19 hospitalization in elderly at a 94% rate

by Peter Heck · Apr 29th, 2021 9:17 am

Last Updated May 1st, 2021 at 9:32 pm

A recent study has found both the Pfizer and Moderna COVID-19 vaccines are 94% effective at preventing hospitalizations in people aged 65 and older.

The real-world study that was published this week by the Centers for Disease Control and Prevention also found that just one dose of the two-dose vaccine was effective 64% of the time.

"This multisite U.S. evaluation under real-world conditions suggests that vaccination provided protection against COVID-19–associated hospitalization among adults aged ≥65 years," the study found. "Vaccination is a critical tool for reducing severe COVID-19 in groups at high risk."

The findings corroborate what health authorities had reported seeing in plummeting hospitalization rates among the elderly dating back to when the vaccines first became available.

The CDC has found that more than 81% of Americans in the oldest age bracket have received at least one dose of the vaccine and more than 67% have received both shots.

"The results are promising for our communities and hospitals," CDC Director Dr. Rochelle Walensky said. "As our vaccination efforts continue to expand, COVID-19 patients will not overwhelm health care systems – leaving hospital staff, beds, and services available for people who need them for other medical conditions."


There are 25 comments on this article.

You must become a subscriber or login to view or post comments on this article.